跳至主要内容
临床试验/JPRN-UMIN000002653
JPRN-UMIN000002653招募中未知

A study on the effects of eicosapentaenoic acid (EPA) on arteriosclerosis in hemodialysis patients with percutaneous coronary intervention (PCI) - A study on the effects of eicosapentaenoic acid (EPA) on arteriosclerosis in hemodialysis patients with percutaneous coronary intervention (PCI)

agoya Kyoritsu Hospital0 个研究点目标入组 100 人开始时间: 2009年11月1日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 75years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1) A history of hypersensitivity to highly purified EPA preparations. 2) Have had the onset of stroke within the past 6 months. 3) Left ventricular ejection fraction below 40%. 4) Are currently pregnant or may be pregnant. 5) Suffering from hemorrhage (e.g., hemophilia, capillary fragility, gastrointestinal hemorrhage, urinary tract hemorrhage, hemoptysis and vitreous hemorrhage). 6) A peptic ulcer. 7) Extremely poor bile secretion or severe hepatic dysfunction. 8) Others judged to be inappropriate to participate in the current study.

研究者

发起方
agoya Kyoritsu Hospital

相似试验